当前位置:首页 - 行情中心 - 共同药业(300966) - 财务分析

共同药业

(300966)

  

流通市值:17.19亿  总市值:25.95亿
流通股本:7636.82万   总股本:1.15亿

共同药业(300966)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-0.37亿元,每股收益-0.28元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益95790.55万元,未分配利润25837.98万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产285676.27万元,负债189885.72万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入455,071,340.26302,399,640.34139,216,213.1536,595,592.03
营业总成本505,144,105.05327,673,538.83144,964,043.16573,756,838.18
其他经营收益
营业利润-52,441,061.48-21,819,689.85-4,323,869.32-42,421,941.53
利润总额-53,658,033.91-23,157,693.17-4,383,203.85-45,535,155.39
净利润-37,430,322.36-14,654,445.7-762,780.33-31,656,138.87
每股收益
其他综合收益----
综合收益总额-37,430,322.36-14,654,445.7-762,780.33-31,656,138.87
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计779,686,448.17854,580,712.74872,425,299.25769,997,377.12
非流动资产:
非流动资产合计2,077,076,297.232,080,593,817.292,041,127,263.592,019,882,951.74
资产总计2,856,762,745.42,935,174,530.032,913,552,562.842,789,880,328.86
流动负债:
流动负债合计762,840,757.28821,744,569.28827,325,074.65807,687,044.23
非流动负债:
非流动负债合计1,136,016,467.931,116,108,568.71,074,163,156.26967,551,229.64
负债合计1,898,857,225.211,937,853,137.981,901,488,230.911,775,238,273.87
所有者权益(或股东权益):
归属于母公司股东权益合计871,396,588.82909,318,935.08922,404,814.76923,137,679.57
股东权益合计957,905,520.19997,321,392.051,012,064,331.931,014,642,054.99
负债和股东权益合计2,856,762,745.42,935,174,530.032,913,552,562.842,789,880,328.86
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计412,169,849.05222,850,365.81107,168,250.73636,351,939.69
经营活动现金流出小计418,335,857.41228,643,260.64135,942,532.26656,940,387.32
经营活动产生的现金流量净额-6,166,008.36-5,792,894.83-28,774,281.53-20,588,447.63
投资活动产生的现金流量:
投资活动现金流入小计133,709133,709133,30917,275,865.13
投资活动现金流出小计141,243,927.94115,639,950.7782,259,738.98311,613,852.76
投资活动产生的现金流量净额-141,110,218.94-115,506,241.77-82,126,429.98-294,337,987.63
筹资活动产生的现金流量:
筹资活动现金流入小计413,800,628.84280,029,384.62133,865,714.47780,091,146.66
筹资活动现金流出小计285,227,544.88160,996,327.6437,842,705.97460,687,056.14
筹资活动产生的现金流量净额128,573,083.96119,033,056.9896,023,008.5319,404,090.52
汇率变动对现金及现金等价物的影响-43,987.3689,458.955,663.29-561,781.53
现金及现金等价物净增加额-18,747,130.7-2,176,620.72-14,822,039.723,915,873.73
期末现金及现金等价物余额81,374,902.3297,945,412.385,299,993.3100,122,033.02
补充资料:
现金及现金等价物的净增加额--2,176,620.72-3,915,873.73
最新报告期:2025-10-27
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
太平洋周豫,乔露阳-0.460.150.592025-10-27
太平洋周豫,乔露阳-0.290.150.592025-09-05
TOP↑